Vaccinex, Inc. (VCNX)
NASDAQ: VCNX · Real-Time Price · USD
3.499
-0.141 (-3.88%)
Nov 21, 2024, 11:26 AM EST - Market open

Vaccinex Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
-18.58-20.25-19.82-22.38-28.85-31.86
Upgrade
Depreciation & Amortization
0.10.120.210.170.310.25
Upgrade
Loss (Gain) From Sale of Investments
------0.04
Upgrade
Stock-Based Compensation
0.390.470.550.540.730.45
Upgrade
Other Operating Activities
22.11--0.420.23-
Upgrade
Change in Accounts Receivable
-0.05-0.79-0.180.160.74-0.26
Upgrade
Change in Accounts Payable
0.640.520.46-2.110.120.73
Upgrade
Change in Unearned Revenue
0.050.06----
Upgrade
Change in Other Net Operating Assets
-0.40.52-0.29-1.26-1.930.03
Upgrade
Operating Cash Flow
-15.85-17.23-19.07-25.3-28.65-30.72
Upgrade
Capital Expenditures
-0.02-0.07-0.1-0.03-0.29-0.08
Upgrade
Investment in Securities
-----14.15
Upgrade
Investing Cash Flow
-0.02-0.07-0.1-0.03-0.2914.07
Upgrade
Long-Term Debt Issued
----9.13-
Upgrade
Long-Term Debt Repaid
--0.07-0.08-8.54-0.11-
Upgrade
Net Debt Issued (Repaid)
-0.08-0.07-0.08-8.549.03-
Upgrade
Issuance of Common Stock
9.9912.5217.0532.8528.4913.8
Upgrade
Other Financing Activities
7.03---0.99-0.76-
Upgrade
Financing Cash Flow
18.6512.4516.9823.3236.7613.8
Upgrade
Net Cash Flow
2.78-4.86-2.2-2.017.82-2.84
Upgrade
Free Cash Flow
-15.87-17.3-19.17-25.33-28.94-30.79
Upgrade
Free Cash Flow Margin
-4089.69%-3035.26%-6972.00%-2814.44%-4629.92%-5887.76%
Upgrade
Free Cash Flow Per Share
-10.27-37.31-94.88-184.38-323.46-502.03
Upgrade
Levered Free Cash Flow
-11.93-11.11-11.8-17.07-18.49-18.73
Upgrade
Unlevered Free Cash Flow
-11.93-11.11-11.8-16.57-18.19-18.73
Upgrade
Change in Net Working Capital
-0.22-2.670.013.191.23-0.66
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.